Biomarkers in lungCA: For stage 4 non-small cell lung cancer -- specifically adenocarincoma -- i would check the biomarkers alk and egfr. The response rate with oral drugs for those targets is ~80% vs. 20% with chemo. Bone mets can be treated with bisphosphonate (zometa) or Denosumab (xgeva). Palliative care provided early has a survival benefit. Ref: temel et al. Nejm http://www.Nejm.Org/doi/pdf/10.1056/nejmoa1000678.
Answered 12/13/2019
5.8k views
Hospice: Palliative of pain and comfort care only.
Answered 11/9/2017
5.8k views
2 doctors weighed in across 2 answers
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
6 doctors weighed in across 5 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question